Health eHeart BioBank
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · May 8, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The Health eHeart BioBank is a clinical trial aimed at collecting and storing samples like blood, DNA, and tissue from people to help researchers at the University of California, San Francisco (UCSF) learn more about heart diseases. By studying these samples, scientists hope to find important changes and markers in the body that could lead to better ways to diagnose and treat heart disease, ultimately helping to detect and prevent these conditions faster.
To participate, you need to be at least 18 years old and meet certain criteria. You might qualify if you are a current patient at UCSF, a participant in another study that uses the BioBank, or a family member of someone with heart disease. You can also join if you do not have heart disease yourself. Participants will be asked to provide consent for their samples to be collected, and if you choose to join, you will be contributing to important research that could benefit many people in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years or older.
- And at least one of the following:
- • Established patient seen at UCSF and/or is a current participant in a clinical study that utilizes the HeH BioBank for biospecimen collection.
- • Family member of a patient with cardiovascular disease.
- • Patient with no cardiovascular disease.
- Exclusion Criteria:
- • Unwilling to consent to biospecimen collection through the HeH BioBank.
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Jeffrey E Olgin, MD
Principal Investigator
University of California, San Francisco
Gregory Marcus, MD
Principal Investigator
University of California, San Francisco
Vasanth Vedantham, MD
Principal Investigator
University of California, San Francisco
Connor G O'Brien, MD
Principal Investigator
University of California, San Francisco
James P Pirruccello, MD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported